Cumberland Advisors Inc Bristol Myers Squibb CO Transaction History

Cumberland Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$61.48 - $73.72 $7.81 Million - $9.36 Million	-127,031 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$53.63 - $62.52 $240,530 - $280,402	4,485 Added 3.66%	127,031 $7.92 Million
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $1.07 Million - $1.25 Million	18,035 Added 17.26%	122,546 $7.25 Million
Q2 2021 Jul 12, 2021	BUY	$61.91 - $67.42 $328,804 - $358,067	5,311 Added 5.35%	104,511 $6.98 Million
Q1 2021 Apr 20, 2021	BUY	$59.34 - $66.74 $2.02 Million - $2.27 Million	34,075 Added 52.32%	99,200 $6.26 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $171,199 - $193,999	2,965 Added 4.77%	65,125 $4.04 Million
Q2 2020 Jul 20, 2020	BUY	$54.82 - $64.09 $3.41 Million - $3.98 Million	62,160 New	62,160 $3.66 Million

2,449

1.51B

29.7M

32.1M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cumberland Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Cumberland Advisors Inc with notifications on news.